These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3248160)

  • 1. Study of content and uniformity of content of tablets prepared with a low concentration in active ingredient.
    Gayot A; Blouet E; Leterme P; Traisnel M
    Boll Chim Farm; 1988; 127(9-10):218-20. PubMed ID: 3248160
    [No Abstract]   [Full Text] [Related]  

  • 2. Light induced fluorescence for predicting API content in tablets: sampling and error.
    Domike R; Ngai S; Cooney CL
    Int J Pharm; 2010 May; 391(1-2):13-20. PubMed ID: 20156535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the analytical error on content uniformity sampling plans.
    Norberg R
    Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537
    [No Abstract]   [Full Text] [Related]  

  • 4. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis.
    Li W; Bagnol L; Berman M; Chiarella RA; Gerber M
    Int J Pharm; 2009 Oct; 380(1-2):49-54. PubMed ID: 19576977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of surface area measurement for identifying the source of batch-to-batch variation in processability.
    Vippagunta RR; Pan C; Vakil R; Meda V; Vivilecchia R; Motto M
    Pharm Dev Technol; 2009; 14(5):492-8. PubMed ID: 19241221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Active ingredient release from solid drug forms--test methods, evaluation, influencing parameters].
    Knop K
    Pharm Unserer Zeit; 1999 Nov; 28(6):301-8. PubMed ID: 10614132
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of content uniformity of tablets with a low content of the active ingredient with a narrow therapeutic index].
    Muselík J; Franc A
    Ceska Slov Farm; 2012 Dec; 61(6):271-5. PubMed ID: 23387856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of different laser irradiation methods for quantitative Raman tablet assessment.
    Johansson J; Pettersson S; Folestad S
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):510-6. PubMed ID: 15950422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Random mixing of drug forms with low content of active substance (2)].
    Egermann H; Pesendorfer J
    Pharm Acta Helv; 1986; 61(1):10-4. PubMed ID: 3952101
    [No Abstract]   [Full Text] [Related]  

  • 11. Raman mapping of low-content active-ingredient pharmaceutical formulations. part II: statistically optimized sampling for detection of less than 1% of an active pharmaceutical ingredient.
    Sasić S; Whitlock M
    Appl Spectrosc; 2008 Aug; 62(8):916-21. PubMed ID: 18702866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of mean potency and content uniformity of tablets: a new approach.
    Comer JP; Breunig HL; Broadlick DE; Sampson CB
    J Pharm Sci; 1970 Feb; 59(2):210-4. PubMed ID: 5411343
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of content uniformity test to tablet preparations.
    Kovács I; Hadady KK; Darbai MJ
    Pharmazie; 1980; 35(10):609-12. PubMed ID: 6779284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
    Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
    Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validity of Higuchi's Law in the case of tablets with a high concentration of active principle].
    Fessi H; Puisieux F; Marty JP; Carstensen JT
    Pharm Acta Helv; 1980; 55(10):261-9. PubMed ID: 7454733
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of weight uniformity, content uniformity and 30-day stability in halves and quarters of routinely prescribed cardiovascular medications.
    Margiocco ML; Warren J; Borgarelli M; Kukanich B
    J Vet Cardiol; 2009 Jun; 11(1):31-9. PubMed ID: 19477704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-scored tablets. Weight and content uniformity of subdivisions and distribution of active constituent within and between tablets.
    Walker J; Abdulsalam A; Theobald AE; Subrahmanyam R; Verma SK
    J Pharm Pharmacol; 1978 Jul; 30(7):401-6. PubMed ID: 27603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.